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Abstract: Extensive research documents the health inequalities LGBTI people experience, however
far less is known for people with intersex variation. This paper presents a review of intersex health
and healthcare inequalities by evaluating research published from 2012 to 2019. In total 9181 citations
were identified with 74 records screened of which 16 were included. A synthesis of results spans
nine quantitative, five qualitative and two narrative reviews. Literature was searched in Medline,
Web of Science, Cochrane, PsycInfo and CINAHL. People with intersex variance experience a higher
incidence of anxiety, depression and psychological distress compared to the general population
linked to stigma and discrimination. Progressive healthcare treatment, including support to question
normative binaries of sex and gender, aids understand of somatic intersex variance and non-binary
gender identity, especially when invasive treatment options are avoided or delayed until individuals
are able to self-identify or provide consent to treatment. Findings support rethinking sex and gender
to reflect greater diversity within a more nuanced sex-gender spectrum, although gaps in research
remain around the general health profile and the healthcare experiences of people with intersex
variance. More large-scale research is needed, co-produced with peers who have lived experience of
intersex variation to ensure policy, education and healthcare advances with greater inclusivity and
ethical accountability.
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1. Introduction
The twenty first century is marked by an increasing awareness of gender, sex and sexual plurality
with recognition of how these factors may impact on health and wellbeing. Recent global public
health research reflects significant health inequalities for lesbian, gay, bisexual, trans and intersex
(LGBTI) people compared to the general population. Large scale international reviews collating these
research findings include studies of LGBTI health inequalities [1,2], the disease burden in gender
and sexual minorities [3], intersex health [4], the global health burden and needs of transgender
populations [5], the health profile of sexual minority women [6], and more recently, loneliness
and social support in older LGB communities [7]. These studies share a common denominator
of an increasing concern over how diverse identities and bodies intersect and experience health
inequalities in LGBTI populations. Inequalities are compounded when LGBTI people access healthcare,
with discrimination, heteronormativity or minority stress based on their gender identity, sexual
orientation or sex characteristics [8]. Practitioners working in health and social care settings are tasked
with understanding the specific needs of LGBTI people in a context of evolving practice, changing
terminology and emerging policy directives [9].
Whilst previous research has indicated that LGBTI people experience significant health inequalities
impacting both on their health outcomes and on their experiences of healthcare systems [10–12],
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populations within LGBTI health inequalities research constitute a range of non-homogenous groups.
For these groups a key priority identified in research is the health of people with intersex variance.
Although people with intersex variations are often included in the LGBTI umbrella, community-based
organisations and service users actively resist these framings due to the specificity of intersex health
and healthcare needs [13,14].
1.1. Intersex Variance
People with intersex variations are estimated to form between 1.7% to 4% of the general
population [15–17]. People are born with or develop intersex variance as physical, hormonal or genetic
features. These variations relate to a range of physical traits that lie outside the binary, medical or social
norms of male and female [18]. Male or female representation of sex traits therefore remains problematic
for people with intersex variance as they are too often confined, made invisible or problematised in
this continuing use of dominant binary categories. Conceptualisations of intersex variation benefits
from a non-binary understanding of sex that moves beyond male or female ideals [8,14]. Furthermore,
naïve or simplistic readings or understandings of intersex variance are to be avoided. The complex
politics of claiming an intersex identity is revealed in theoretical debates as this may include people
who identify as intersex (as an identity category), without having the variation in biological physical,
hormonal or genetic sex characteristics [4].
Thus intersex embodiment frames sex as a spectrum, rather than a binary, which then makes
visible the many forms of intersex variance that exist. Even within biomedicine, genetics and human
biology, scientists have argued for a more varied representation of sex and contemporary representations
support these notions of human sex spanning beyond male or female binary sex, and basing representation
on a more nuanced sex spectrum [19]. Given that a range of intersex variations exist, framing sex as a
spectrum serves to further trouble the notion of apriori biologically determined sex and the stability of
an individuated, liberal healthcare subject. However social pressure to conform to binary sex norms is
immense [19].
Further work is needed to respect and promote the fundamental rights of people with intersex
variance globally such as the right to bodily integrity and self-determination combined with the right
to decline biomedical interventions where preferred [18]. People with intersex variance are more likely
to report incidents of lifetime and everyday discrimination compared to the general population and
may experience higher levels of unpredictable, episodic and day to day ‘minority’ stress because of
discrimination and stigmatisation leading to social isolation and limited understanding of their lives
by others. These factors can act as significant barriers where people with intersex variance access
health and social care services [4,14,20]. Moreover, the need for research including people with these
variations is widely reported within contemporary health research [4,20,21].
1.2. Intersex Healthcare
As the concept of intersex relates to variations that lie outside binary ideals of male and female,
people with intersex variance may be exposed to biomedical interventions, including hormonal
treatment or surgery on minors to align their bodies with typical male/female sex characteristics, with
complex challenges around provision of informed consent. For some people with intersex variance
these interventions may have lifelong consequences due to surgical scarring, the continuation of surgery
into adulthood or the effects of trauma linked to surgery that combines with the emotional impact of
discrimination and stigma. The following citation poignantly states: I was sixteen when I first received an
intersex diagnosis, though that wasn’t the terminology used. I had gone to a general practitioner—I hesitate to say
“my” general practitioner, as regular physician visits were an irregularity in the hovering-around-the-poverty-line
world of my adolescence—to find out why I hadn’t begun to menstruate. After multiple visits, bloodwork,
and trips to specialists, I was told that I wouldn’t be able to have children, that my body needed a bit of a push if
it were going to more adequately “feminize” [22]. (Malatino 2019: p. 15).
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Critical Intersex Studies and Critical LGBTI Liberationist lenses, for example, question the need
for these processes of alignment and argue for non-normative formulations of human sex [4,20].
Furhtermore, ethical concerns persist in healthcare practice, particularly around lack of adequate
information and lack of informed consent for practices ranging from anatomical photography through to
application of so-called ‘normalising’ genital surgery on minors with intersex variance. Misconceptions
of health professionals are often based on intersex embodiment being poorly understood as the
assumption of binary male/female sex persists.
Evidence suggests that people with intersex variance are more likely than the general population
to report unfavourable experiences of accessing healthcare including poor communication from health
professionals and dissatisfaction with the treatment and care received [4,20]. Health professionals
commonly accept male/female binary sex as a norm and express surprise when they learn of intersex
variance [14], but feel unsure of how to accommodate the specific health needs of these individuals.
Their health needs are often poorly understood by health professionals due to limited knowledge and
understanding [2]. Opportunities for learning are inadequate as people may avoid disclosing their
intersex variance mostly out of fear of curiosity or comments of health professionals [4,20].
Associated with healthcare, the lives of some people with intersex variance are unnecessarily
medicalised via biomedical terminology describing intersex variations as ‘disorders of sex development’
(DSM), as differentiated in Figure 1.
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self-identify [8]. Although the benefit of biomedical assessment and related interventi n for c nditions
such as Ullrich-Turner syndrome or Klinefelter syndrome may be acknowledg d, activists representi g
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as a biological differenc instead of a medical pathology [4,24,25]. However intersex variations may
be unnecess rily medicalised in healthcare settings where tegorisations such as ‘disorders of
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development’ (DSD) persist [26]. Even though the World Health Organisation in 2018 replaced gender
identity disorder with gender incongruence, understood as ‘a marked and persistent incongruence
between a person’s experienced gender and their assigned sex’, these changes to the International
Classification of Diseases (ICD-11) benefit trans and non-binary people only. Efforts continue to
de-medicalise and de-pathologise ‘disorders of sex’ development for people with biological intersex
variance, particularly where these terms are at odds with how people self-identify [27–29]. One helpful
strategy exists in deconstructing these medical labels. The power deployed via the medicalisation
of people with intersex variance can be reduced when diagnostic labels are interrogated, perceived
as socially constructed terminology, utilised or withdrawn for strategic purposes either to access
treatment or to avoid labelling and blend in [27].
2. Methods
The paper presents a review of the health and healthcare inequalities for people with intersex
variation by addressing the following key question: What are the health inequalities and the experiences
of accessing healthcare for people with intersex variance? The approach was selected to identify
and consolidate research in the area by cutting across a developing field and representing multiple
perspectives spanning biomedicine, health sciences and bioethics. Though the review may not deliver
specific answers to given health concerns for people with intersex variance, the literature study may aid
practitioners, policy makers and researchers to tackle problems bridging the field to inform education,
policy and future research [3].
2.1. Search Strategy
Systematic searches were undertaken in five electronic databases [Medline (including PubMed),
Web of Science, Cochrane Database of Systematic Reviews, PsycInfo, CINAHL]. Google Scholar was
searched where further papers were identified in addition to reviewing the references for the selected
papers. Searches undertaken in 2020 included results from prior searches conducted in 2016 for an
associated project [8].
2.2. Inclusion Criteria
For the purposes of the review, people with intersex variance were studied as a whole group
rather than referring to individual somatic intersex variations. Studies with participants who identified
as intersex for political or gender identity purposes were excluded from the search. Where research
included LGBTI (lesbian, gay, bisexual, trans and intersex) participants, only studies that made explicit
reference to data collected with intersex participants were included. Although aggregating data for
different groups can be useful for research impact purposes, it does blur important issues which may be
particular to each group and merit specific attention [8]. As a result this review considered health and
healthcare inequalities by actively prioritising people with intersex variance. Papers were reviewed
for inclusion if they were: (i) primary qualitative, quantitative or mixed methods research; (ii) or
systematic reviews or narrative synthesis. Papers were eligible if they were published in English with
an accompanying full text for participants with intersex variance, without any age or geographical
restriction. Grey literature, reports, unpublished research and theoretical papers were excluded.
Studies were included if published in peer reviewed journals within any setting and made
available in the period between 2012 to 2019 to ensure currency of the included studies and following the
UN affirming the legal obligations of ‘States to safeguard the human rights of LGBT and intersex people’
in 2012 [30]. This UN document ‘Born free and equal: Sexual orientation and gender identity in international
human rights law’ made visible discrimination intersex people may experience, and affirmed that all people
irrespective of sex, sexual orientation or gender identity are entitled to enjoy the protections provided for
by international human rights law including in respect of rights to life, security of persons and privacy,
the right to be free from torture, arbitrary arrest and detention, the right to be free from discrimination etc.
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2.3. Key Search Terms
Search terms with alternative key terms in Medical Subject Heading (MESH) were utilised for the
purposes of database search engines and included (1) ‘intersex *’ or ‘disorders of sex development’ or
‘hermaphrodit*’ and (2) ‘health *’ and (3) ‘healthcare’ or ‘health care’ and (4) ‘inequalit *’ or ‘disparit*’
or ‘inequit *’ or ‘determinant’.
2.4. Data Extraction
The initial search delivered 9181 papers with Figure 2 indicating how papers were chosen.
Full texts of 74 papers were screened for possible inclusion with primary research papers (n = 14) and
reviews (n = 2) included in the synthesis that follows. EndNote x9 software was utilised to extract
papers from electronic databases by assessing the titles and abstracts for suitability. The identified
papers were retrieved as full texts and screened where they met the inclusion criteria. These papers
were independently extracted with references of included papers scanned by one reviewer, with the
synthesis checked by a second reviewer.
Int. J. Environ. Res. Public Health 2020, 17, x 5 of 19 
 
Search terms with alternative key terms in Medical Subject Heading (MESH) were utilised for 
the purposes of database search engines and included (1) ‘intersex *’ or ‘disorders of sex 
development’ or ‘hermaphrodit*’ and (2) ‘health *’ and (3) ‘healthcare’ or ‘health care’ and (4) 
‘inequalit *’ or ‘disparit*’ or ‘inequit *’ or ‘determinant’. 
2.4. Dat  Extr ction 
The initial search delivered 9181 papers with Figure 2 indicating how papers were chosen. Full 
texts of 74 papers were screened for possible inclusion with primary research papers (n = 14) and 
reviews (n = 2) included in the s nthesis that follows. EndNote x9 software was utilised to extract 
papers from electronic databases by assessing the titles and abstracts for suitability. The identified 
papers were retrieved as full texts and screened where they met the inclusion criteria. These papers 
were independently extracted with references of included papers scanned by one reviewer, with the 
synthesis checked by a second reviewer. 
 
Figure 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow 
diagram. 
Figure 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Int. J. Environ. Res. Public Health 2020, 17, 6533 6 of 19
Table 1. Characteristics of included studies.
Authors, Year Country Design Population Participant Numbers Outcome of Interest
Bennecke et al., 2015 Germany, Austriaand Switzerland
Multicentre clinical
evaluation with ‘dsd’
questionnaire and SPSS
statistical analysis
Young people diagnosed with
‘dsd-XX or XY without (c) or
with partial (p) androgen effects,
and female (f) or male (m) sex
of rearing: dsd-XX-p-f, dsd-
XY-p-f, dsd-XY-p-m and
dsd-XY-c-f.
children
and adolescents (n = 329) and
parents (n = 110)
(1) Parents of children with ‘dsd’ have a
significant need for psychological support. (2)
Half of parents did not receive support. (3)
Support should be part of multidisciplinary care
of parents to reduce their fears of stigmatisation
and to discuss gender issues, hormonal
treatment and surgery of their child.
Berglund et al., 2018 Denmark
Nationwide registry study
with random selection of
participants and a control
cohort with statistical
analysis
46,XY females with Androgen
insensitivity (AIS), GD, 17α
-OHD, 17beta-HSD, WT-1 and
Star mutation
XY females (n = 123), with a
control cohort of females
(n = 12,300) and males
(n = 12,300) from the general
population
(1) Mortality and education were similar to
controls. (2) Cohabitation and motherhood were
reduced for XY females compared to the controls.
(3) Income and performance in the labour
market were higher amongst in XY females later
in life compared to the general population.
D’Alberton et al., 2015 Italian
Cross-sectional study
with standardised (ABCL,
WHOQOL)
questionnaires
46,XY females with ‘dsd’ with
AIS, Gonadal dysgenesis, 5α
-reductase deficiency, Leydig
cell hypoplasia
(n = 43) aged 18–57 years
(1) Statistically higher scores than the
comparison group for depression, anxiety,
internalising and externalising problems. (2)
Younger people were more likely to access
psychological support. (3) Lower psychological
distress in younger women could indicate
positive outcomes of changes in management.
Davis 2014 USA
In-depth individual
interviews standpoint
feminist analysis
Individuals with intersex traits (n = 37)
(1) ‘dsd’ terminology is received and utilised in
different ways, embraced by some and refuted
by other participants. (2) Self-understanding
might conflict with the ‘dsd’ terminology
ascribed in the 1990s.
Meoded Danon 2018 Israel andGermany Narrative interviews
People with intersex variations,
medical professionals, parents
Total (n = 62) German adults
with intersex variations
(n = 4), parents (n = 4),
professionals (n = 18); and
Israeli adults with intersex
variations (n = 15),
professionals (n = 34), parents
(n = 11)
(1) Health professional expressed range of views
regarding people with intersex variance, sex as a
spectrum, treatment options and whether
intervention is needed or not. (2) The
importance of intersex children meeting each
other for support. (3) Legal reform can help
prevent unnecessary surgery on minors with
intersex variance.
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Table 1. Cont.
Authors, Year Country Design Population Participant Numbers Outcome of Interest
Hughes 2018 Australia
Survey (SF12 and with a
Likert scale and Kessler
10) with statistical and
bivariate analysis
LGBTI older people
LGBT people (n-312),
older adult with intersex
variance (n = 1)
(1) Though many older LGBTI people are well,
both physically and mentally, they do appear to
face increased risk of certain health issues
compared with the general population such as
loneliness and psychological distress. (2)
Participants with intersex variation were
underrepresented in the sample.
Jones 2016 Australian
Survey with a descriptive
comparative statistical
analysis
People with intersex variations People with intersex variance(n = 272) aged 16 to 87 years
(1) 42% of participants thought about self-harm
on the basis of issues related to having an
intersex variation (2) 26% had engaged in
self-harm on the basis of having an intersex
variation. (3) 60% had thought about suicide,
and 19% had attempted suicide compared to
under 3% for the general Australian population.
Jones 2018 International
Systematic review of
health literature via
theoretical lenses
People with intersex variations Studies published in2015–2016 (n = 61)
(1) studies framing medical interventions as
problematic (n = 27). (2) studies using a
bioethical/narrative inquiry frame (n = 26). (3)
Studies with clinical medical theoretical lens
(n = 24). (4) Studies with a critical LGBTI
liberationist theoretical lens (n = 4).
Jurgensen et al., 2013 Germany, Austria,Switzerland
Questionnaire via
interviews with statistical
analysis
People with ‘dsd’ Adolescents (n = 66) andadults (n = 110)
(1) Partnership and sexuality were identified as
challenging areas of life. (2) Fewer experiences
of peer, romantic or sexual relationships were
reported compared to the general population. (3)
25% of adults with ‘dsd’ never had a love
relationship and will benefit from support and
counselling.
Köhler et al., 2012 Germany, Austria,Switzerland
Evaluation via
questionnaire with
statistical analysis
Individuals with ‘46,XY,dsd’ People with intersex variance(n = 57) aged 18–62
(1) Constructive genital surgery should be
minimised and only undertaken with informed
consent mainly in adolescence or adulthood. (2)
Multidisciplinary care and psychological
support should include parents, peers and
patient groups.
Ojanen et al., 2018 Thailand Life story interviews withthematic analysis LGBTI people
A person with intersex
variance (n = 1)
(1) Transgender and intersex participants
reported more discrimination and exclusion
compared to LGB people. (2) Lower
socio-economic status of LGBTI people results in
vulnerability.
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Table 1. Cont.
Authors, Year Country Design Population Participant Numbers Outcome of Interest
Thyen et al., 2014 Germany, Austria,Switzerland
Clinical evaluation via
cross-sectional assessment
with statistical analysis in
SPSS
People with intersex variations Adults with ‘dsd’ (n = 110)
(1) People with intersex variance should have
access to mental health services as part of
interdisciplinary care. (2) long-term follow-up
should include measures of satisfaction with
care and subjective psychosexual, emotional,
and social well-being.
Sanders et al., 2015 UK
Interpretive
phenomenological
analysis
Young people with intersex
variations
Young women with ‘dsd’
aged 14–19 (n = 13)
(1) Young women may fear sharing personal
information (2) Physical intimacy may require
planning which has an impact on their perceived
expectation of sexual spontaneity in a
relationship. (3) For those who can’t have
children meaning given to fertility change over
time.
Schweizer et al., 2014 Germany
Questionnaire,
standardised scales,
qualitative content and
statistical analysis
People with intersex variations
Young people and adults with
‘dsd’
(n = 78)
(1) 24% of participants reported an inclusive
two-gender/mixed identity and 3% neither male
nor female gender identity. (2) Uncertainty of
belonging to the female or male gender category
as well as non-binary identifications highlight
the need for alternative gender categories.
Wang and Tian 2015 China Case-control with SPSSstatistical analysis Patients with ‘dsd’
People with ‘dsd’ (n = 87)
aged 13–38
(1) Only 13.7% of participants partook in sexual
activity. (2) Quality of life of ‘dsd’ patients are
not significantly lower compared to the urban
Chinese population.
Zeeman et al., 2018 International
Narrative synthesis of
systematic reviews,
meta-synthesis and
primary research
LGBTI people
Studies of people with
intersex variations (n = 8)
published 2010–2016
(1) A significant lack of research exists on the
general health profile and healthcare
experiences of intersex people. (2) Unessential
corrective surgery on intersex minors to align
their bodies to the male/female binary should
only occur when the young person can provide
informed consent. (3) Intersex variations are
diagnosed biomedically which unnecessarily
medicalises intersex people. (4) Male/female
binary categories for sex markers and gender
identify are not helpful as intersex bodies can be
‘trapped’ in these limiting categories.
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Summaries of the features for the included papers combined with their findings were logged in
Microsoft Excel (Table 1). Studies were appraised via the Critical Appraisal Skills Programme (CASP)
framework for qualitative (Table 2), quantitative or mixed methods (Table 3), and review papers
(Table 4) with the aim to follow a consistent approach across all studies. Where questions within the
appraisal framework did not have a clear answer, for example assessing the value of the quantitative
research (no 10), these questions were excluded.
Table 2. Critical Appraisal Skills Programme (CASP) quality assessment of qualitative studies.
No Study 1 2 3 4 5 6 7 8 9 10
1 Davis 2014 [27] y y y y y y y y ct y
2 Meoded Danon 2018 [31] y y y y y y y y ct y
3 Jones 2016 [32] y y y y y ct y y y y
4 Ojanen et al., 2019 [33] y y y y y y y y y y
5 Sanders et al., 2015 [34] y y y y y ct y y y y
Checklist questions were: 1. Was there a clear statement of the aims of the research? 2. Is a qualitative methodology
appropriate? 3. Was the research design appropriate to address the aims of the research? 4. Was the recruitment
strategy appropriate to the aims of the research? 5. Was the data collected in a way that addressed the research
issue? 6. Has the relationship between researcher and participants been adequately considered? 7. Have ethical
issues been taken into consideration? 8. Was the data analysis sufficiently rigorous? 9. Is there a clear statement of
findings? 10. How valuable is the research? Abbreviations: Y—yes; CT—cannot tell; N—no; N/A—not applicable.
Table 3. Critical Appraisal Skills Programme (CASP) quality assessment of quantitative studies.
No Study 1 2 3 4 5a 5b 6a 6b 9 10 11
1 Bennecke et al., 2015 [35] y y y y ct ct y ct y y y
2 Berglund et al., 2018 [36] y y y y ct ct y y y y y
3 D’Alberton [37] y y y y ct ct y y y y y
4 Hughes 2018 [38] y ct ct ct y y ct ct y ct y
5 Jürgensen et al., 2013 [39] y y y y y y ct n/a y y y
6 Köhler et al., 2012 [18] y y y y y y ct ct y y y
7 Thyen et al., 2014 [20] y y y y y y y y y y y
8 Wang and Tian 2015 [40] y y y y y y ct ct ct ct ct
9 Schweizer 2014 [41] y y y y y y ct y y y y
Checklist questions were: 1. Did the study address a clearly focused issue? 2. Was the cohort recruited in an
acceptable way? 3. Was the exposure accurately measured to minimise bias? 4. Was the outcome accurately
measured to minimise bias? 5a. Have the authors identified all important confounding factors? 5b. Have they
taken account of the confounding factors in the design and/or analysis? 6a. Was the follow up of subjects complete
enough? 6b. Was the follow up of subjects long enough? 9. Do you believe the results? 10. Can the results be
applied to the local population? 11. Do the results of this study fit with other available evidence? Abbreviations:
y—yes; ct—cannot tell; n—no; n/a—not applicable.
Table 4. Critical Appraisal Skills Programme (CASP) quality assessment of reviews.
No Study 1 2 3 4 5 6 7 8 9 10
1 Jones 2018 [4] y y ct n/a n/a n/a ct y y n/a
2 Zeeman et al., 2018 [1] y y y n/a y y y y y n/a
Checklist questions were: 1. Did the review address a clearly focused question? 2. Did the authors look for the right
type of papers? 3. Were all the important, relevant studies included? 4. Did the authors assess the quality of the
included studies? 5. If the results of the review have been combined, was it reasonable to do so? 6. What are the
overall results of the review? 7. How precise are the results? 8. Can the results be applied to the local population? 9.
Were all important outcomes considered? 10. Are the benefits worth the harms and costs? Abbreviations: Y—yes;
CT—cannot tell; N—no; N/A—not applicable.
2.5. Synthesis
The results for quantitative or mixed methods studies (n = 9), qualitative studies (n = 5) and
reviews (n = 2) were presented as a narrative synthesis. Meta-analysis of the quantitative research
could not be undertaken as studies included a range of different designs and outcomes measures.
One researcher identified themes that were later verified by a second researcher. Quotes extracted
from the research were available to reflect specific notions that emerged across data. Qualitative,
quantitative and review results were combined to lend value to the body of evidence in its entirety.
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3. Results
The results will present the review findings to address the health inequalities and the experiences
of accessing healthcare for people with intersex variance. Research reporting on intersex health and
healthcare is limited and often small-scale, ranging from one participant in Hughes [38], to 123 in
Berglund et al. [36], and 329 in Bennecke et al. [35]. A synthesised summary of what is known follows.
3.1. Mental Health
An Australian survey of people with intersex variance (n = 272) aged 16 to 87 found being
diagnosed with a ‘DSD’ or ‘disorders of sex development’ and the related medical intervention,
had a range of both physical and psychological effects with young people experiencing isolation
due to stigma, bullying, discrimination or rejection from family or peers [32]. Consequently 26%
of people with intersex variations in the sample have engaged in self-harm with the incidence of
suicide attempts were 19%. As many as 60% had considered suicide, compared to under 3% of
the general Australian population [32]. An Italian cross-sectional study of individuals with 46,XY
‘disorders of sex development’ (n = 43) including Androgen insensitivity syndrome (AIS), complete
gonadal dysgenesis (GD), 5α-reductase deficiency and Leydig cell hypoplasia, found higher rates of
psychological distress including depression and anxiety in women with intersex variance amongst
study participants compared to the general population [37].
However research indicated that support to address these problems were available in some
settings. A study undertaken in Germany, Austria and Switzerland for people with intersex variance
(n = 110), found in 11% of participants (n = 12) access to psychological support services in the form
of counselling or talking therapies to help maintain mental health, significantly increased patients’
satisfaction with healthcare. Research recommends that individuals with intersex variance should
have access to long term follow-up and mental health services as part of interdisciplinary care, to
maintain mental health from childhood to adulthood [20]. Within these services that were effective,
long-term follow up included assessment of psychosexual, emotional and social wellbeing [18,20].
3.2. Assigned Sex
For some people with intersex variance, binary notions sex may be challenging where their bodies
spanned binary sex characteristics, with related implications for their gender identity. In the Australian
survey of people with intersex variations (n = 272), 52% of participants reported having been assigned
female sex at birth. Of these participants, the same proportion (52%) continued to use the same
assignation at the time of the survey. Amongst all participants, 41% were assigned male sex at birth,
with 23% continuing to use the same male assignation. However some participants assigned male sex
at birth, may over time have changed their gender identity when they were older. In this same study,
8% of participants identified as being trans due to disagreeing with medical practitioners about their
assigned sex [32].
3.3. Gender Identity
As seen above, in the Australian study where 41% of male participants (n = 272), assigned male
sex at birth changed their gender identity over time, with 8% of the total participants later identifying
as trans [32]. This study reflects the complexity of sex and gender, where individuals disagreed with
medical practitioners’ assessment of their physical sex characteristics and changed their assigned sex as
they became older, with related implications for gender identity. Where gender identities and gender
roles of people with intersex variance fell beyond the gender binary, they represented neither male
nor female gender roles, but instead wanting to ‘live as that which I am’. A mixed-methods study
with people with intersex variance (n = 69) undertaken in Germany, found gender expression was
more flexible and associated with the right to an ‘authentic and intersexual self’ falling beyond binary
identity [41]. Study findings identified for the total population that gender allocation at birth was
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female in 83% and male in 17%, with 75% of people satisfied with their gender allocation. Of these
people as adults, 81% lived in the female gender role and 12% living in the male role, with as many
as 7% opting for other roles. Over time 9% reported a change in their gender. More significantly
24% reported an inclusive or mixed gender that combined male and female components, with 3%
identifying as neither male nor female. Of the total participants (n = 69), 26% expressed significant
uncertainty regarding belonging to a specific gender. The study highlights how binary categories
of gender do not represent the gender for a substantial proportion of people with intersex variance
who participated in the study that identified as mixed or both (24%), and neither or non-binary
(3%). Findings support the need to reconsider sex [32], and gender [41], to reflect greater diversity
by preventing people with intersex variance from being ‘trapped’ in, or reduced by these limiting
categories. Further research recommends that the gender identity of young people should be respected
including when they identify as non-binary, whilst approaching puberty and beyond [18].
3.4. Healthcare
Research found a range of healthcare associated concerns for people with intersex variance ranging
from problematic sexual experiences after medical intervention [40], dissatisfaction with treatment and
surgery [20], combined with sexual desire problems [18], and an absence of patient or service user
consultation regarding their health needs [40]. Furthermore the views and choices regarding their
own treatment preferences were not being heard by health professionals or taken into account during
clinical decision-making [27]. More detailed accounts of these studies follow.
3.5. Surgery
Research findings challenged assumptions that early surgery to feminise or masculinise the
bodies of people with intersex variance where there is difference, is in the best interest of these
individuals [18,20]. In a European study with (46, XY) people with intersex variance (n = 57) who had
undergone genital surgery, 47% were unhappy with the outcome of surgery, 70% had problems with
sexual desire and 56% described symptoms of dyspareunia whilst 44% XY males feared sexual contact
compared to 81% XY females. Overall dissatisfaction with sex life of XY females were 42% compared
to 11% for the general female population [18]. As the negative impact of surgery has been highlighted
for health and wellbeing, researchers recommend that early feminising surgery should be avoided at
birth, and gonadectomy should only take place where there is a risk of gonadal malignancies and in
consultation with parents along with the child or young person. In addition, non-emergency surgical
intervention should be reduced to a minimum [41], and should only take place with full informed
consent in accordance to patient’ needs preferably in puberty and adulthood [18,31,42]. More recent
studies report a departure from performing unessential surgery on children and young people in
Australia [32], and Germany [31,42]. Parents should be informed of the diagnosis of their child at the
earliest opportunity and should be consulted with their child during decision-making about treatment
options and care pathways. Where possible the child should be assigned to the most likely gender,
and where this is not possible a decision to rear a child in a specific gender should be delayed and left
open to ensure the family consult the child whilst their gender evolves [18].
3.6. Health Professionals
Health professionals held a range of views regarding intersex variation that are informed by
biomedical knowledge and sociocultural norms. People with intersex variance are assessed in clinical
healthcare settings where, what constitutes male or female bodies is subjected to biomedical scrutiny.
Along these lines a qualitative study conducted in-depth interviews with medical professionals,
parents and people with intersex variance (n = 62) in ‘DSD’ centres based in Israel and Germany
respectively to understand how medical guidelines for treatment of ‘disorders of sex development’
shaped intervention. Where the bodies of young children were assessed based on sex binaries,
the related treatment reflected the views of health professionals and whether intervention was required
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or not. Israeli practice included ‘normalising’ surgical intervention to align the bodies of young
children to male/female sex characteristics, whereas German practice avoided unnecessary surgery,
and instead offered parents psychological support to understand somatic variance [42]. The following
quotations reflect a range of views expressed by health professionals in the two settings with significant
implications for intersex children:
. . . nature has decided (tapping the table) that there should be a female and a male and when they
are together then you can have a baby, yes? There is a God and he decided that it should be this
way. With human beings and with all animals it’s the same: there are female and male animals.
[42] (Prof. K., 29 October 2015 in Meoded Danon 2019 p. 150).
Based on social and cultural norms, this quote reflects the engrained binary notion of biological
sex that fails to take account of variation in sex characteristics that moves beyond or exceeds male and
female sex.
. . . First, when these children are born, they have genitalia that are neither male nor female, and society
cannot accept this. This family seems bizarre to society. How will they put him in a kindergarten?
Second, from a technical point of view, healing is faster, and there is a great advantage in doing these
operations at a young age. Third, psychologically, a girl [in this case] also has to grow up knowing that
she is more or less normal. She will grow up with female genitalia and not some intermediate thing
that appears to be something more masculine. So, the goal is to fix these children between the age of six
months and a year. This is the optimum age. (Prof B., 25 Oct 2015 in Meoded Danon [42] p. 156).
The above quote reflects the normative ideal based on male and female sex with the bodies of
those who do not fit the binary needing to be ‘fixed’. We could ask, are these bodies ‘broken’? If they
are fixed what are the consequences for those who did not consent to invasive medical intervention?
Where intervention is not essential, if the binary notion of sex was disrupted, could sex be reframed
where more diverse sex characteristics are accounted for?
I say what I always say, which is ‘we are happy that your child is healthy. We don’t need to do
anything. Everything is fine. Look at your beautiful child’. I will say this several times, so it is
clear that there is no deal [no rush to do anything] now. So they will not do anything, I tell them
what I think is most important so they can connect to their child. (Dr. E., 28 November 2015 in
Meoded Danon [42], p. 155).
In this quote the health professional puts parents at ease by laying the emphasis on the ‘health’ and
‘beauty’ of the child instead of medicalising what is in essence a biological variation in sex characteristics.
We really want to avoid early operations. We seriously spend a lot of time talking about the need to
open our minds to the fact that we have more than two “drawers”, boys or girls, that it is a task for
society to see the whole spectrum, that it is a challenge for the family to understand that this child
is special and that we should wait until the child is able to express an opinion with his own voice.
So regarding everything that has to do with correcting the genitalia we are very, very, very careful.
(Dr. M., 8 April, 2016 in Meoded Danon [42], p. 155).
The above quote reflects the notion of sex as a spectrum that incorporates a range of sex
characteristics beyond male and female. When this view is held by health professionals, the need for
early unnecessary intervention is reduced. These quotations show how sociocultural norms of sex
and gender inform biomedical practice around the absence or presence of surgical intervention for
children with intersex variance in different international healthcare settings. With adequate specialist
treatment that includes psychological support for parents, early unnecessary surgery can be avoided
or delayed until young people are able to decide for themselves and provide informed consent for
invasive treatment options. Where health professionals and parents understood sex as a spectrum,
children were approached with appreciation for their variance. These views afforded children greater
flexibility as their gender identity evolved over time.
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3.7. Accessing Healthcare
Communication between people with intersex variance and those involved in their care and
socialisation had a significant impact on psychological wellbeing. Poor communication between health
professionals, the family and the patient combined with secrecy or stigma related to people with
intersex variation, adds to the psychological burden of these conditions [20,31]. UK based research
with young women based on their intersex variance (n = 13) aimed to understand their experiences of
sharing information with health professionals, friends and partners. The research found that where
health professionals feared adverse responses from young women, they were less likely to disclose
medical information. Improved communication and support may be needed following healthcare
consultations where important information is shared by health professionals such as young women with
intersex variance learning they may not be able to have children [38]. Improved communication with
greater psychosocial support could help young people understand their intersex variance, particularly
where they may experience adverse reactions from others following disclosure of sensitive personal
information [32].
In the Thyen et al., study with German, Austrian and Swiss participants (n = 110), 28% of
those who participated experienced difficulties whilst accessing specialist care. Participants who did
not understand the diagnosis at the time of disclosure reported significantly lower levels of patient
satisfaction compared to the average satisfaction for all patients. Of the study sample, 11% of intersex
participants reported being offered counselling or talking therapies to help them make sense of events
in adulthood. 28% reported that they had been offered such services but that they had no need for
them, however the majority of participants had never been offered access to psychological support
services. Those who had never been offered psychological support reported the lowest satisfaction
with care. Thus access to psychosocial support services appears to increase patient satisfaction with
healthcare [20].
3.8. Parenting
In the German DSD Network study with children who have intersex traits aged 8–12 (n = 86),
parents of these children expressed significant uncertainty of when and how to disclose or speak to
their child about their intersex variance [39,43]. Related research later evaluated the clinical outcomes
for individuals with ‘DSD’. The study included children and adolescents with their parents (n = 439)
based in Austria, Switzerland and Germany. Research found a significant need for psychological
support in parents of young people with intersex variance to help them consider the gender issues of
their child where they may exist, and to reduce parents’ fears of stigmatisation [35]. Positive outcomes
were noted for young people with intersex variance in settings where parental support groups were
available. These groups aided parents to support their children and adolescents whilst they attempted
to understand and make sense of their bodily variation [42].
3.9. Age
A number of studies included young people, for example the Italian study with adult females with
46, XY DSD (n = 43) who were accessing treatment with a comparison group of 46, XX healthy women
(n = 43) found younger women with intersex variance showed better psychosocial adjustment and
quality of life in the social arena comparand to older ones [37]. For this study psychological support
was offered to 39% of the entire sample of 43. Of these 46% considered the support useful. 55% of
younger women were offered psychological support compared to 47% of the older subgroup (p = 0.041).
Younger individuals required psychological care more often and earlier in the younger group than
in the older group (70% vs. 35% respectively; p = 0.034). Younger women were informed of their
condition significantly earlier that those who were older (mean age 16.5–4.2 vs. 21.2–8.6; p = 0.048).
Furthermore younger women showed significantly better quality of life in the social arena (66.6–75
vs. 66.7–58.3; p = 0.003). However, less research is available for people with intersex variance who
Int. J. Environ. Res. Public Health 2020, 17, 6533 14 of 19
are older. An Australian survey with older LGBTI people (n = 312) including an intersex participant,
highlighted a dearth in research with very few studies addressing the mental health, social support
and loneliness of people with intersex variance as they age [38].
3.10. Social Factors
The European study that evaluated the surgical outcomes and sexual life of (XY, DSD) people
with intersex variance (n = 57) found for younger people their peer, romantic or sexual relationships
were challenging areas of life, leading to high levels of sexual anxiety [18]. Related findings of a
German clinical evaluation that assess psychosexual development in adolescent (n = 66) and adult
(n = 110) individuals with intersex variance, found that for adults, 25% never had a romantic or
intimate relationship [39]. Guarding against disclosing personal information was seen as a form of
self-preservation or protection against potential hostile reactions [34]. The following quote of a young
woman with intersex variance reflects difficulties around intimate relationships.
It’s hard for people like me to get a steady functional intimate relationship. Because if you think about
it you’ve got your medical problems to explain for one and a lot of people these days are only out for
one thing (sex) and you can’t just tell everyone that you can’t, things get round too fast. You have got
to be careful. Everyone says you can have a decent life without a relationship, I don’t think that’s true.
I’m sure there is, [someone like me] somewhere out there but I wouldn’t even speak to them about it all,
because it’s just too awkward (a young woman in Sanders et al. [34], p. 1909).
Alongside challenges with social relationships, broader socioeconomic aspects may be influenced
for people with intersex variance. A Danish nationwide registry study with 46, XY females (n = 123)
including Androgen insensitivity (AIS), GD, 17α -OHD, 17β-HSD and Star mutation described the
morbidity, mortality and socioeconomic status of these women in comparison to the general population
during the period from 1960 to 2012. Participants were compared to a randomly selected aged-matched
control cohort of 12,300 females and 12,300 males in the general population. Where the education,
income, cohabitation, motherhood and retirement of people with intersex variance were compared
to the general population, cohabitation and motherhood including the prospect of family life were
reduced for females with intersex variation. However, education was similar to the general population,
or slightly higher achievement was found for education and professional life for those with intersex
variation over time [36].
Life story research based in Thailand with LGBTI people (n = 19) including a participant with
intersex variation (n = 1), reported that experiences of discrimination may lead to unemployment
and lower socio-economic status in a national setting where there was less or no legal protection
in the workplace [33]. Conversely the Danish study reported that income for females with intersex
variance was higher compared to the general population where they performed well in the labour
market [32]. Thus socio-economic status for people with intersex variance varied across geographical
areas depending on the level of income and whether legislation protected people against discrimination
in the workplace [33,36].
4. Discussion
4.1. Summary of Findings
This review consolidates research undertaken in biomedicine, health sciences and bioethics
and evidences a range of health inequalities for people with intersex variance. These inequalities
can be seen in increased levels of psychological distress such as anxiety and depression compared
to the general population or social isolation, stigma, discrimination and/or rejection from others.
More positively, the availability of psychological support and counselling services increased patient
satisfaction for both young people, adults and their parents, particularly where parents were uncertain
of how to speak to their child about their intersex variance, or where they feared stigmatisation when
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the gender identity or assigned sex of the young person did not reflect binary male/female ideals.
Improved communication with greater professional support can help young people to understand
their own intersex variance in situations where they may experience adverse reactions from others
following disclosure of sensitive personal information. Peer, romantic or sexual relationships were
perceived as challenging, with many individuals with intersex variance avoiding romantic or intimate
relationships as a form of self-preservation or as protection against potential hostile reactions from
others. Cohabitation and motherhood, including the prospect of family life, were reduced for people
with intersex variance compared to the general population. The socio-economic status for people with
intersex variance varied across geographical settings depending on a range of factors including the
level of legal protection against discrimination in the workplace.
Where sex norms persisted, these binary ideals were reflected in the views of health professionals
and the treatment guidelines they followed. A range of intersex variations are diagnosed biomedically
which continue to unnecessarily medicalise people with intersex variance based on their somatic
variance. These terms are often incongruous with how people with intersex variance define themselves.
This is reinforced in current framings of intersex variance as ‘disorders of sex development’ persist in
systems of classification such as the WHO International Classification of Diseases (ICD-11) or the APA
Diagnostic and Statistical Manual of Mental Disorders (DSM-V). The impact of this medicalisation of
intersex variance is reduced when diagnostic labels are perceived as socially constructed terminology,
utilised or withdrawn by people with intersex variance for strategic purposes either to gain access
to biomedical treatment or to blend in. Where descriptions of bodily variation in pathological terms
persist, surgical intervention informed by biomedical knowledge and sociocultural norms continue in
international healthcare settings. Some research on the health of people with intersex variance relates
to surgical intervention dedicated to assigning sex within the male/female binary, sometimes without
gaining consent where surgery concerns minors with intersex traits. Promising practice is evident in
specialist treatment centres that includes psychological support, where unessential surgery is delayed
or avoided until people with intersex variance can self-identify or provide fully informed consent to
undergo invasive treatment options. In settings where health professionals resisted binary notions of
sex, people were approached with appreciation for their somatic variance, whilst their gender evolved
over time. Review findings support the need to rethink sex and gender to reflect greater diversity,
particularly where people identify as non-binary within the gender-sex spectrum.
4.2. Strengths and Limitations of the Review
With regards to the methodological approach followed for the review, the lack of independent
screening and extraction of papers in duplicate would have increased rigour and is therefore regarded
as a limitation. A further limitation is not undertaking the study with a prospective protocol. Prior
registration of a prospective protocol with Prospero would have aided the review. A number of
studies included people with intersex variance in research with lesbian, gay, bisexual, trans and
intersex groups [1,33,38]. Studies combined groups often within rights, legal or policy considerations
to maximise visibility and collective impact [8]. Although aggregating data for diverse groups can
be useful for analytical purposes and research impact, it does blur important issues which may be
specific to each group and their related health or healthcare needs [4]. Therefore by recognising the
merits of research separating groups into more nuanced component parts and disaggregating data for
people with intersex variance in particular, this review provides a synthesis of health and healthcare
research for people with intersex variance as a distinct group. Furthermore this review differs from
prior studies that either focused on health inequalities of LGBTI people [1,8], or explored conceptual or
theoretical lenses for representation of intersex health more broadly in a review of research including
grey literature from 2015–2016 [4]. This is a strength of this study insofar as expanding knowledge by
drawing on existing studies in the field, and adding to content with a more defined critique of research
and an accompanying focus on the healthcare inequalities of people with intersex variance.
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With the exception of Chinese, Israeli and Thai studies included in the review, research represented
was mainly undertaken in Australia, Europe, USA, Switzerland and the UK. As a result the literature
can be regarded as biased insofar as representing largely Western views. Future reviews should include
more nuanced representation for a range of geographical settings to reflect varying sociocultural and
legal factors globally that will shape the experiences of people with intersex variance where they
access healthcare.
4.3. Implications for Research
The review found a lack of substantive research on the general health and cancer burden of people
with intersex variance. Further large-scale research is needed to understand the general health profile
for those with intersex variance and their experiences of accessing healthcare. Very few studies address
mental health [44], or the psychological wellbeing and social support of people with intersex variance
as they age [4,45]. Thus limited information is currently available for this group where gender, sex and
age intersect.
Research will benefit from theoretical underpinning by emergent theories with a specific focus on
the material and embodied realities of people with intersex variance. Theory informed research will
raise crucial questions around how to represent and empirically investigate identities and subjectivities
that are in a state of flux and constantly evolving with greater ethical accountability [46]. In health
research, how do we meaningfully investigate the embodied processes for people with intersex
variance? Research is required to explore:
• How meanings or understandings of intersex subjectivity and embodiment materialise as
multi-layered forms of interdependence via health assemblages.
• How to achieve dynamic systems change via disruption of biomedical linguistic essentialism (as
seen in ‘DSD’ diagnoses), whilst questioning sex and gender normativity in healthcare.
• What these forms of resistance might look like.
Research informed by theory should be undertaken with a specific focus on intersex health in
greater consultation and peer involvement of people with intersex variance, as they understand their
own health needs and experiences of accessing services. Where this is unattainable and LGBTI research
includes people with intersex variance, their goals should be actively prioritised in the research [4].
Co-producing research with peers who have experiential knowledge and lived experience should
be a priority, by involving people with intersex variation at every level from conception, design
to undertaking the research [2]. This kind of research should co-constitute materiality with more
intersubjective methodologies and ethically accountable healthcare practice.
5. Conclusions
Given continuing biomedically informed understandings of sex variation, it is no surprise that
restrictive clinical conceptualisations of the health or healthcare for people with intersex variance
persists within health sciences. This medicalisation of the bodies and lives of people with intersex
variance are, for some, accompanied by damaging consequences and disparities with lived subjective
experience. For others, this provides much needed access to treatment, hormonal and surgical
intervention. Although substantial contemporary research is concentrated within biomedicine or
health sciences and bioethics, there is some critical, patient-centred, community driven and theory
informed work becoming visible. Emergent thinking and activism reflected in health research is
marking a shift in the way intersex variance is framed by drawing attention to the ethical and political
implications associated with such healthcare practices. Where practice is based on the continuation
of normative gender and sex binaries, combined with the pathologising language of biomedicine,
discursive, embodied and material tensions become more apparent. Both politically and ethically, these
familiar normative binary sex and gender framings remain in tension with the equal rights afforded
through equalities legislation and in settings where gender and sex are protected characteristics.
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However further work is needed to ensure equalities legislation takes account of more varied sex
characteristics that span the binary male or female spectrum. Political questions and challenges to
unwanted medical and healthcare interventions, and as importantly, demands for greater ethical
accountability from healthcare professionals, are being voiced and heard. Much scope remains to
address the general health profile and the subjective embodied experiences of people with intersex
variance when they access healthcare. Research should be coproduced alongside peers with intersex
variance, including those who are older, to inform practice, research and policy. Co-production or
coproduced research in healthcare is an approach that brings together the public, practitioners and
researchers to generate more meaningful knowledge. This is research that starts from the premise of
inclusivity of all knowledges, skills and perspectives, is based upon values of respect and reciprocity,
and most importantly, fully considers question of power, with the sharing of and joint ownership
of research [47,48]. These levels of recognition throughout the research process, and especially
in healthcare research, are vitally important for people with intersex variance, given the evidence
presented here of ongoing objectification, misrecognition, marginalisation or exclusion. Coproduced
research generating awareness of subjective lived experiences and learning from intersex activism will
enable more acceptable, responsive and appropriate research which can lead to more inclusive and
affirming encounters with healthcare. Central to this, and any healthcare practice, will be the need to
interrogate, undo and rethink sex and gender to make visible and fully recognise greater diversity.
Healthcare may then become more authentically appropriate and accessible to all within the gender
and sex spectrum.
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